X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene.

Dyskeratosis congenita is a rare inherited bone marrow-failure syndrome characterized by abnormal skin pigmentation, nail dystrophy, and mucosal leukoplakia. More than 80% of patients develop bone-marrow failure, and this is the major cause of premature death. The X-linked form of the disease (MIM 305000) has been shown to be caused by mutations in the DKC1 gene. The gene encodes a 514-amino-acid protein, dyskerin, that is homologous to Saccharomyces cerevisiae Cbf5p and rat Nap57 proteins. By analogy to the homologues in other species, dyskerin is predicted to be a nucleolar protein with a role in both the biogenesis of ribosomes and, in particular, the pseudouridylation of rRNA precursors. We have determined the genomic structure of the DKC1 gene; it consists of 15 exons spanning a region of 15 kb. This has enabled us to screen for mutations in the genomic DNA, by using SSCP analysis. Mutations were detected in 21 of 37 additional families with dyskeratosis congenita that were analyzed. These mutations consisted of 11 different single-nucleotide substitutions, which resulted in 10 missense mutations and 1 putative splicing mutation within an intron. The missense change A353V was observed in 10 different families and was shown to be a recurring de novo event. Two polymorphisms were also detected, one of which resulted in the insertion of an additional lysine in the carboxy-terminal polylysine domain. It is apparent that X-linked dyskeratosis congenita is predominantly caused by missense mutations; the precise effect on the function of dyskerin remains to be determined.

[1]  A. Poustka,et al.  Dyskeratosis Congenita Caused by a 3′ Deletion: Germline and Somatic Mosaicism in a Female Carrier , 1999 .

[2]  A. Poustka,et al.  Dyskeratosis congenita caused by a 3' deletion: germline and somatic mosaicism in a female carrier. , 1999, Blood.

[3]  T. Vulliamy,et al.  Dyskeratosis Congenita (DC) Registry: identification of new features of DC , 1998, British journal of haematology.

[4]  A. Poustka,et al.  1.4 Mb candidate gene region for X linked dyskeratosis congenita defined by combined haplotype and X chromosome inactivation analysis. , 1998, Journal of medical genetics.

[5]  C. Cadwell,et al.  The Nop60B gene of Drosophila encodes an essential nucleolar protein that functions in yeast , 1998, Molecular and General Genetics MGG.

[6]  J. Goldman,et al.  Chromosomal breakage analysis in dyskeratosis congenita peripheral blood lymphocytes , 1998, British journal of haematology.

[7]  S. Klauck,et al.  X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions , 1998, Nature Genetics.

[8]  L. Luzzatto,et al.  Dyskeratosis and ribosomal rebellion , 1998, Nature Genetics.

[9]  D. Tollervey,et al.  The box H + ACA snoRNAs carry Cbf5p, the putative rRNA pseudouridine synthase. , 1998, Genes & development.

[10]  B. Zonneveld,et al.  The lysine‐rich C‐terminal repeats of the centromere‐binding factor 5 (Cbf5) of Kluyveromyces lactis are not essential for function , 1998, Yeast.

[11]  R. Planta,et al.  The yeast gene YNL292w encodes a pseudouridine synthase (Pus4) catalyzing the formation of psi55 in both mitochondrial and cytoplasmic tRNAs. , 1997, Nucleic acids research.

[12]  C. Cadwell,et al.  The yeast nucleolar protein Cbf5p is involved in rRNA biosynthesis and interacts genetically with the RNA polymerase I transcription factor RRN3 , 1997, Molecular and cellular biology.

[13]  T. Vulliamy,et al.  Skewed X-inactivation in carriers of X-linked dyskeratosis congenita. , 1997, Blood.

[14]  A. Ferraris,et al.  Nonrandom X-chromosome inactivation in hemopoietic cells from carriers of dyskeratosis congenita. , 1997, American journal of human genetics.

[15]  M. Alikaşifoğlu,et al.  Dyskeratosis congenita with an unusual chromosomal abnormality. , 1997, British journal of haematology.

[16]  K. Devriendt,et al.  Skewed X-chromosome inactivation in female carriers of dyskeratosis congenita. , 1997, American journal of human genetics.

[17]  S. Kenwrick,et al.  Linkage Analysis in 16 Families with Incontinentia pigmenti , 1997, European journal of human genetics : EJHG.

[18]  E V Koonin,et al.  Pseudouridine synthases: four families of enzymes containing a putative uridine-binding motif also conserved in dUTPases and dCTP deaminases. , 1996, Nucleic acids research.

[19]  P. Patel,et al.  Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion , 1996, Science.

[20]  J. Gécz,et al.  Splicing mutation in the ATR-X gene can lead to a dysmorphic mental retardation phenotype without alpha-thalassemia. , 1996, American Journal of Human Genetics.

[21]  I. Dokal Dyskeratosis congenita: an inherited bone marrow failure syndrome , 1996, British journal of haematology.

[22]  W. Miller,et al.  T-->A transversion 11 bp from a splice acceptor site in the human gene for steroidogenic acute regulatory protein causes congenital lipoid adrenal hyperplasia. , 1995, Human molecular genetics.

[23]  J. Ofengand,et al.  Purification, cloning, and properties of the tRNA psi 55 synthase from Escherichia coli. , 1995, RNA.

[24]  G. Blobel,et al.  NAP57, a mammalian nucleolar protein with a putative homolog in yeast and bacteria [published erratum appears in J Cell Biol 1998 Jan 26;140(2):447] , 1994, The Journal of cell biology.

[25]  L. Luzzatto,et al.  Dyskeratosis congenita is a chromosomal instability disorder. , 1994, Leukemia & lymphoma.

[26]  A. Smahi,et al.  The gene for the familial form of incontinentia pigmenti (IP2) maps to the distal part of Xq28. , 1994, Human molecular genetics.

[27]  K. Middleton,et al.  An essential yeast protein, CBF5p, binds in vitro to centromeres and microtubules , 1993, Molecular and cellular biology.

[28]  B. Alter,et al.  Dyskeratosis Congenita: Clinical and Genetic Heterogeneity Report of a New Case and Review of the Literature , 1992, The American journal of pediatric hematology/oncology.

[29]  G. Blobel,et al.  Nopp 140 shuttles on tracks between nucleolus and cytoplasm , 1992, Cell.

[30]  D R Bentley,et al.  A variable number of tandem repeats locus within the human complement C2 gene is associated with a retroposon derived from a human endogenous retrovirus , 1992, The Journal of experimental medicine.

[31]  W. Krone,et al.  Cytogenetic studies of skin fibroblast cultures from a karyotypically normal female with dyskeratosis congenita , 1992, Clinical genetics.

[32]  R. Heilig,et al.  Rapid PCR analysis of the St14 (DXS52) VNTR. , 1991, Nucleic acids research.

[33]  G. Loudianos,et al.  Molecular characterization of beta-thalassemia intermedia in patients of Italian descent and identification of three novel beta-thalassemia mutations. , 1991, Blood.

[34]  G. Pai,et al.  Bleomycin hypersensitivity in dyskeratosis congenita fibroblasts, lymphocytes, and transformed lymphoblasts. , 1989, Cytogenetics and cell genetics.

[35]  D. Labie,et al.  A novel beta thalassemia gene with a single base mutation in the conserved polypyrimidine sequence at the 3' end of IVS 2. , 1988, Nucleic acids research.

[36]  M. Ono,et al.  A novel human nonviral retroposon derived from an endogenous retrovirus. , 1987, Nucleic acids research.

[37]  J. Connor,et al.  Assignment of the gene for dyskeratosis congenita to Xq28 , 1986, Human Genetics.

[38]  Stephen M. Mount,et al.  A catalogue of splice junction sequences. , 1982, Nucleic acids research.